Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
114.66
-1.10 (-0.95%)
Apr 25, 2025, 4:00 PM EDT - Market closed

CRL Market Cap

CRL has a market cap or net worth of $5.63 billion as of April 25, 2025. Its market cap has decreased by -57.35% in one year.

Market Cap
5.63B
Enterprise Value
8.17B
1-Year Change
-57.35%
Ranking
Category
Stock Price
$114.66

Market Cap Chart

Since June 23, 2000, CRL's market cap has increased from $226.30M to $5.63B, an increase of 2,388.56%. That is a compound annual growth rate of 13.81%.

History

DateMarket Cap% Change
Apr 24, 20255.92B-37.28%
Dec 31, 20249.44B-22.16%
Dec 29, 202312.13B9.38%
Dec 30, 202211.09B-41.69%
Dec 31, 202119.01B52.98%
Dec 31, 202012.43B66.59%
Dec 31, 20197.46B37.05%
Dec 31, 20185.44B5.01%
Dec 29, 20175.18B43.75%
Dec 30, 20163.61B-3.79%
Dec 31, 20153.75B25.52%
Dec 31, 20142.99B17.00%
Dec 31, 20132.55B40.28%
Dec 31, 20121.82B34.64%
Dec 30, 20111.35B-34.13%
Dec 31, 20102.05B-7.60%
Dec 31, 20092.22B25.20%
Dec 31, 20081.77B-60.32%
Dec 31, 20074.47B54.46%
Dec 29, 20062.89B-5.57%
Dec 30, 20053.06B2.77%
Dec 31, 20042.98B89.75%
Dec 31, 20031.57B-9.52%
Dec 31, 20021.74B17.55%
Dec 31, 20011.48B50.25%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.72B
UnitedHealth Group 379.88B
Johnson & Johnson 369.09B
AbbVie 328.25B
Novo Nordisk 276.96B
Abbott Laboratories 222.53B
AstraZeneca 215.41B
Novartis AG 211.71B
Market Cap Rankings